COSTANTINO, GIUSEPPE

COSTANTINO, GIUSEPPE  

Mostra records
Risultati 1 - 20 di 20 (tempo di esecuzione: 0.03 secondi).
Titolo Data di pubblicazione Autore(i) File
Azathioprine/6-Mercaptopurine in the treatment of inflammatory bowel disease (IBD)- A single centre experience. 1-gen-2008 Costantino, Giuseppe; Sergi, M. D.; Ocera, L.; Lo Presti, M. A.; DELLA TORRE, Anna; Romano, C.; Di Benedetto, A.; Fries, Walter
Clinical practice in the management of ulcerative colitis - an Italian survey 1-gen-2008 Fries, Walter; Costa, S; Costantino, Giuseppe; Familiari, Luigi
Effectiveness of Ustekinumab on Crohn‘s Disease Associated Spondyloarthropathy: Real-World Data from the Sicilian Network for Inflammatory Bowel Diseases (SN-IBD) 1-gen-2020 Macaluso, F. S.; Fries, W.; Viola, A.; Costantino, G.; Muscianisi, M.; Cappello, M.; Guida, L.; Giuffrida, E.; Magnano, A.; Pluchino, D.; Ferracane, C.; Magri, G.; Di Mitri, R.; Mocciaro, F.; Privitera, A. C.; Camilleri, S.; Garufi, S.; Renna, S.; Casa, A.; Scrivo, B.; Ventimiglia, M.; Orlando, A.
Fecal calprotectin correlates with intestinal permeabilità (IP) in patients with Crohn’s disease. 1-gen-2006 Fries, Walter; M. A., Lo Presti; DELLA TORRE, Anna; Costantino, Giuseppe; L., Drago; DI PASQUALE, Giuseppe; G. C., Sturniolo
Ileal tight junction (TJ) alterations associated with experimental colitis – a time course. 1-gen-2005 E., Mazzon; Costantino, Giuseppe; DELLA TORRE, Anna; Cuzzocrea, Salvatore; Fries, Walter
Infliximab and etanercept are equally effective in reducing enterocyte apoptosis in experimental colitis. 1-gen-2008 Fries, Walter; Muja, C; Crisafulli, Concetta; Costantino, Giuseppe; Longo, Giuseppe; Cuzzocrea, Salvatore; Mazzon, E.
Infliximab normalizes intestinal permeability in the short-term but not fecal calprotectin in Crohn’s disease 1-gen-2009 DELLA TORRE, Anna; M. D., Sergi; M. A., Lo Presti; Costantino, Giuseppe; E., Corrente; S., Comunale; R., Pillitteri; M. L., Resta; Fries, Walter
Intestinal gas and liver steatosis: a casual association? A prospective multicentre assessment. 1-gen-2017 Maconi, G; Furfaro, F; Fries, W; Dell'Era, A; Bezzio, C; Costantino, G; Giuliano, V; Alibrandi, A; Guzowski, T; Bassotti, G.
Outcome in ulcerative colitis after switch from adalimumab/golimumab to infliximab: A multicenter retrospective study 1-gen-2019 Viola, Anna; Pugliese, Daniela; Renna, Sara; Furfaro, Federica; Caprioli, Flavio; D'Incà, Renata; Bossa, Fabrizio; Mazza, Stefano; Costantino, Giuseppe; Fantini, Massimo; Fiorino, Gionata; Alibrandi, Angela; Orlando, Ambrogio; Armuzzi, Alessandro; Fries, Walter
Pan-digestive tract colonization by CMV in Common Variable Immunodeficiency. 1-gen-2014 G. Costantino; P. Mondello; M. Previti; W. Fries; V. Villanacci.
Predicting response to thiopurines – a single centre experience. 1-gen-2011 Costantino, Giuseppe; F., Furfaro; Alibrandi, Angela; Fries, Walter
Prevention of post-surgical recurrence with adalimumab in a patient with complicated Crohn's disease. 1-gen-2010 Costantino, Giuseppe; Navarra, Giuseppe; Familiari, Luigi; Fries, Walter
Response evaluation and safety of thiopurines in the treatment of inflammatory bowel diseases (IBD): safety and response evaluation. 1-gen-2011 Costantino, Giuseppe; F., Furfaro; A., Belvedere; Fiorino, Gionata; Alibrandi, Angela; Fries, Walter
Serology of Viral Infections and Tuberculosis Screening in an IBD Population Referred to a Tertiary Centre of Southern Italy 1-gen-2017 Ardesia, Marco; Costantino, Giuseppe; Mondello, Placido; Alibrandi, Angela; Fries, Walter
Thalidomide for refractory bleeding small intestinal Crohn’s disease– a case report 1-gen-2009 DELLA TORRE, Anna; E., Corrente; S., Comunale; M. A., Lo Presti; M. D., Sergi; R., Pillitteri; Costantino, Giuseppe; Fries, Walter
Therapy-related adverse events in Crohn’s disease (CD) – a comparison between thiopurines, infliximab and combined therapy. 1-gen-2011 Fries, Walter; M., Mastronardi; M., Cappello; L., Grossi; F., Furfaro; Costantino, Giuseppe; A., Belvedere; A., Lauria; M., Principi; N., della Valle; N., Buccianti; Alibrandi, Angela; A. C., Privitera
Thiopurine treatment in inflammatory bowel disease: response predictors, safety and withdrawal in follow-up. 1-gen-2012 Costantino, Giuseppe; F., Furfaro; Belvedere, Alessandra; Alibrandi, Angela; Fries, Walter
Thiopurines in the treatment of inflammatory bowel diseases – a single centre experience. 1-gen-2011 F., Furfaro; Costantino, Giuseppe; Alibrandi, Angela; Fries, Walter
Treatment of life threatening type I refractory celiac disease with long term infliximab 1-gen-2008 Costantino, Giuseppe; DELLA TORRE, A.; LO PRESTI, M. A.; Caruso, Rosario; Mazzon, E.; Fries, Walter
Urinary neutrophil gelatinase-associated lipocalin (uNGAL) levels in patients with Crohn’s disease undergoing treatment with infliximab. 1-gen-2010 Costantino, Giuseppe; Bolignano, Davide; DELLA TORRE, Anna; M. A., Lo Presti; Lacquaniti, Antonio; Buemi, Michele; Fries, Walter